Clough Capital Partners’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Clough Capital Partners’s Portfolio CVRS Stock Details CVRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,012,054	Closed	-$707K	–	189
2016 Q4	$707K	Sell	1,012,054 -37,800	-4%	-$31.8K	0.05%	131
2016 Q3	$1.17M	Sell	1,049,854 -48,300	-4%	-$64.6K	0.06%	129
2016 Q2	$1.57M	Sell	1,098,154 -1,029,200	-48%	-$1.19M	0.08%	133
2016 Q1	$2.11M	Buy	2,127,354 +14,400	+0.7%	+$24.7K	0.1%	137
2015 Q4	$6.78M	Buy	2,112,954 +99,700	+5%	+$312K	0.32%	94
2015 Q3	$6.22M	Buy	2,013,254 +8,054	+0.4%	+$29.1K	0.27%	85
2015 Q2	$7.04M	Buy	+2,005,200	New	+$8.55M	0.27%	99

Other funds holding CVRS

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

HEC

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Clough Capital Partners's CVRS Position: Q1 2017 in Review

Clough Capital Partners sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q1 2017, closing a stake of 1,012,054 shares — an estimated $707K sold.

Clough Capital Partners first reported a position in CVRS in Q2 2015 and held it in 7 quarters. The position peaked at $7.04M in Q2 2015. 50 funds tracked by Wall St. Rank hold CVRS as of Q1 2017.

Clough Capital Partners reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q1 2017 after selling out during the quarter.
Clough Capital Partners sold 1,012,054 CORINDUS VASCULAR ROBOTICS, INC shares in Q1 2017, an estimated $707K.
Clough Capital Partners first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q2 2015 and held it in 7 quarters.
Clough Capital Partners's CORINDUS VASCULAR ROBOTICS, INC position peaked at $7.04M in Q2 2015.
50 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q1 2017.

Based on Clough Capital Partners's 13F filing for Q1 2017, filed 15 May 2017.